Monteverde & Associates PC has initiated investigations into four merger and acquisition transactions scheduled for shareholder votes in March 2026. The firm is examining proposed deals involving RAPT Therapeutics, Amicus Therapeutics, Tamboran Resources, and Contango Ore, and is encouraging shareholders to carefully review transaction terms and deadlines before casting their votes.
Shareholders in these four companies face approaching tender offer deadlines and shareholder voting dates in March 2026. Monteverde & Associates is advising affected shareholders to evaluate the proposed transactions and consider their options, noting the importance of timely action given the proximity of key decision dates.
The investigations focus on whether the proposed transactions adequately represent shareholder interests and comply with applicable corporate governance standards. Shareholders seeking additional information about their rights and available actions have been encouraged to contact the firm directly.